The present invention relates to the field of pharmacology and specifically to PDGFRα polypeptides which can be used as viral decoy receptors. It includes fusion proteins comprising these polypeptides as well as nucleic acids, vectors, cells and pharmaceutical compositions. The use in medicine is envisioned specifically for the prevention and treatment of CMV infections.
展开▼
